<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04961437</url>
  </required_header>
  <id_info>
    <org_study_id>2021-A00329-32</org_study_id>
    <nct_id>NCT04961437</nct_id>
  </id_info>
  <brief_title>Impact of Dyspnea, Regional Lung Ventilation, and Diaphragmatic Function During de Novo Acute Respiratory Failure</brief_title>
  <acronym>DY-VI-DI</acronym>
  <official_title>Evaluation of Dyspnea, Pulmonary VentIlation and DIaphragmatic Function in de Novo Adult Acute Respiratory Failure.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Modern management of acute respiratory failure aims to relieve dyspnea and anxiety by&#xD;
      providing a non-invasive respiratory support. This approach tries to avoid endotracheal&#xD;
      intubation, patient self inflicted lung injuries (PSILI) and diaphragmatic dysfunction. The&#xD;
      present study aims to evaluate dyspnea, pulmonary regional ventilation and diaphragmatic&#xD;
      function in patients with hypoxemic acute respiratory failure by different observations, and&#xD;
      to bring risk factor for intubation out.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients aged of 18 years or more, presenting with an acute respiratory failure without&#xD;
      hypercapnia will be included in the study. Clinical and biological variables, dyspnea&#xD;
      assessment, regional lung ventilation (electrical impedance tomography) and diaphragm&#xD;
      function (ultrasound) will be evaluated at inclusion and at 2 hours, 4 hours and 48 hours&#xD;
      after inclusion. In case of intubation, diaphragmatic function will be also evaluated with&#xD;
      phrenic nerve stimulation technique.&#xD;
&#xD;
      Primary endpoint is intubation at day 7. Secondary endpoints are measurement of dyspnea,&#xD;
      pulmonary ventilation and diaphragmatic function, also ventilator free days, ICU length of&#xD;
      stay and mortality.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Oro-tracheal intubation</measure>
    <time_frame>7 days after admission in the ICU</time_frame>
    <description>Patients who will be intubated within the 7 days after admission in the ICU</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diaphragmatic function</measure>
    <time_frame>2 days after inclusion</time_frame>
    <description>using ultrasonography, measure of diaphragmatic excursion and diaphragmatic thickening in Hertz (Hz)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diaphragmatic function</measure>
    <time_frame>2 days after inclusion</time_frame>
    <description>Diaphragmatic function evaluation by phrenic nerve stimulation (only for intubated patients).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lung regional ventilation</measure>
    <time_frame>2 days after inclusion</time_frame>
    <description>As measured with Electric Impedance Tomography index measures (inhomogeneity index, end expiratory lung impedance change)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea evaluation</measure>
    <time_frame>28 days after inclusion</time_frame>
    <description>Dyspnea evaluation using visual analogue scale applied to dyspnea: from 1 to 10, 1 corresponding to &quot;no breathlessness&quot; and 10 to &quot;maximum breathlessness&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea evaluation</measure>
    <time_frame>28 days after inclusion</time_frame>
    <description>Dyspnea evaluation using Respiratory Distress Observation Scale (RDOS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation duration</measure>
    <time_frame>28 days after inclusion</time_frame>
    <description>(only for intubated patients).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>28 days after inclusion</time_frame>
    <description>for all patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>28 days after inclusion</time_frame>
    <description>for all patients</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Acute Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Patients with de novo acute respiratory failure</arm_group_label>
    <description>The following tests will be performed as part of the research (these tests are usually performed as part of routine care but not routinely and comprehensively):&#xD;
A diaphragmatic ultrasound in the half-seated position. Diaphragmatic excursion and thickening fraction will be measured in the right hemi-diaphragm.&#xD;
A 10-minute reference acquisition. They will be performed at inclusion, H2, H4 and H48.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diaphragmatic ultrasound and electrical impedance tomography</intervention_name>
    <description>A diaphragmatic ultrasound in a half sitting position. The diaphragmatic excursion and the thickening fraction of the right hemi-diaphragm will be measured.&#xD;
- Acquisition of 10 minutes of regional pulmonary ventilation by electrical impedance tomography.</description>
    <arm_group_label>Patients with de novo acute respiratory failure</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with de novo acute respiratory failure&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18&#xD;
&#xD;
          -  Acute respiratory insufficiency defined by the three following items :&#xD;
&#xD;
               1. PaO2/ FiO2 &lt;300&#xD;
&#xD;
               2. Respiratory rate &gt; 25/min&#xD;
&#xD;
               3. Oxygen support &gt; 10L/min or High Flow nasal oxygen (HFNO)&#xD;
&#xD;
          -  Non opposition by the patient to be included&#xD;
&#xD;
          -  Social insurance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Respiratory acidosis (pH &lt; 7,35 PaCO2 &gt; 45mmHg or 6kPa)&#xD;
&#xD;
          -  Chronic respiratory disease ( COPD, bronchiectasis…)&#xD;
&#xD;
          -  Cardiogenic Acute lung oedema&#xD;
&#xD;
          -  Non intubation decision at randomisation&#xD;
&#xD;
          -  Contraindication for Electro-impedance tomography-belt placement (chest trauma with&#xD;
             rib fractures, thoracic wound, chest tube).&#xD;
&#xD;
          -  Uncommunicative patient (Glasgow coma scale &lt;12)&#xD;
&#xD;
          -  Guardianship or curators for vulnerable patients.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Martin DRES, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin DRES, MD PhD</last_name>
    <phone>O1 42 16 78 09</phone>
    <email>martin.dres@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sébastien Clerc, MD</last_name>
    <phone>06 47 21 69 77</phone>
    <email>sebastien.clerc@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Groupe Hospitalier Pitié-Salpêtrière&quot;, Intensive care unit</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Martin Dres, MD phD</last_name>
      <phone>01 42 16 78 09</phone>
      <email>martin.dres@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 18, 2021</study_first_submitted>
  <study_first_submitted_qc>July 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2021</study_first_posted>
  <last_update_submitted>August 27, 2021</last_update_submitted>
  <last_update_submitted_qc>August 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute respiratory failure</keyword>
  <keyword>diaphragm</keyword>
  <keyword>dyspnea</keyword>
  <keyword>EIT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Dyspnea</mesh_term>
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

